OS Therapies Inc (OSTX): Form 8-K filed 2026-10-05

Items reported

Item 1.01: Entry into a Material Definitive Agreement
The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements.
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
A director or a named officer (such as the CEO or CFO) left or was appointed, or certain executive compensation arrangements were adopted or changed.
Item 8.01: Other Events
A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news.
Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.

Type	Description	Document
8-K	CURRENT REPORT	ea0307611-8k_ostherapies.htm
EX-10.1	EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 29, 2026, BETWEEN OS THERAPIES INCOR	ea030761101ex10-1.htm
EX-10.2	EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 29, 2026, BETWEEN OS THERAPIES INCOR	ea030761101ex10-2.htm
EX-99.1	PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON OCTOBER 1, 2026	ea030761101ex99-1.htm

This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.